Abstract
The choroid plexuses (CP) release numerous biologically active enzymes and neurotrophic factors, and contain a subpopulation of neural progenitor cells providing the capacity to proliferate and differentiate into other types of cells. These characteristics make CP epithelial cells (CPECs) excellent candidates for cell therapy aiming at restoring brain tissue in neurodegenerative illnesses, including Alzheimer’s disease (AD). In the present study, using in vitro approaches, we demonstrated that CP were able to diminish amyloid-β (Aβ) levels in cell cultures, reducing Aβ-induced neurotoxicity. For in vivo studies, CPECs were transplanted into the brain of the APP/PS1 murine model of AD that exhibits advanced Aβ accumulation and memory impairment. Brain examination after cell implantation revealed a significant reduction in brain Aβ deposits, hyperphosphorylation of tau, and astrocytic reactivity. Remarkably, the transplantation of CPECs was accompanied by a total behavioral recovery in APP/PS1 mice, improving spatial and non-spatial memory. These findings reinforce the neuroprotective potential of CPECs and the use of cell therapies as useful tools in AD.
Similar content being viewed by others
References
Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T et al (2010) Decreased clearance of CNS beta-amyloid in Alzheimer’s disease. Science 330:1774
Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R et al (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416:535–539
Emerich DF, Winn SR, Hantraye PM, Peschanski M, Chen EY et al (1997) Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington’s disease. Nature 386:395–399
Hemming ML, Patterson M, Reske-Nielsen C, Lin L, Isacson O et al (2007) Reducing amyloid plaque burden via ex vivo gene delivery of an Abeta-degrading protease: a novel therapeutic approach to Alzheimer disease. PLoS Med 4:e262
Garcia P, Youssef I, Utvik JK, Florent-Bechard S, Barthelemy V et al (2010) Ciliary neurotrophic factor cell-based delivery prevents synaptic impairment and improves memory in mouse models of Alzheimer’s disease. J Neurosci 30:7516–7527
Spuch C, Antequera D, Portero A, Orive G, Hernandez RM et al (2010) The effect of encapsulated VEGF-secreting cells on brain amyloid load and behavioral impairment in a mouse model of Alzheimer’s disease. Biomaterials 31:5608–5618
Tuszynski MH, Thal L, Pay M, Salmon DP, U HS et al (2005) A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med 11:551–555
Eriksdotter-Jonhagen M, Linderoth B, Lind G, Aladellie L, Almkvist O et al (2012) Encapsulated cell biodelivery of nerve growth factor to the Basal forebrain in patients with Alzheimer’s disease. Dement Geriatr Cogn Disord 33:18–28
Wahlberg LU, Lind G, Almqvist PM, Kusk P, Tornoe J et al (2012) Targeted delivery of nerve growth factor via encapsulated cell biodelivery in Alzheimer disease: a technology platform for restorative neurosurgery. J Neurosurg 117:340–347
Stopa EG, Berzin TM, Kim S, Song P, Kuo-LeBlanc V et al (2001) Human choroid plexus growth factors: what are the implications for CSF dynamics in Alzheimer’s disease? Exp Neurol 167:40–47
Alvira-Botero X, Carro EM (2010) Clearance of amyloid-beta peptide across the choroid plexus in Alzheimer’s disease. Curr Aging Sci 3:219–229
Crossgrove JS, Smith EL, Zheng W (2007) Macromolecules involved in production and metabolism of beta-amyloid at the brain barriers. Brain Res 1138:187–195
Iwata N, Tsubuki S, Takaki Y, Shirotani K, Lu B et al (2001) Metabolic regulation of brain Abeta by neprilysin. Science 292:1550–1552
Leissring MA, Farris W, Chang AY, Walsh DM, Wu X et al (2003) Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron 40:1087–1093
Borlongan CV, Thanos CG, Skinner SJ, Geaney M, Emerich DF (2008) Transplants of encapsulated rat choroid plexus cells exert neuroprotection in a rodent model of Huntington’s disease. Cell Transpl 16:987–992
Emerich DF, Thanos CG, Goddard M, Skinner SJ, Geany MS et al (2006) Extensive neuroprotection by choroid plexus transplants in excitotoxin lesioned monkeys. Neurobiol Dis 23:471–480
Borlongan CV, Skinner SJ, Geaney M, Vasconcellos AV, Elliott RB et al (2004) Intracerebral transplantation of porcine choroid plexus provides structural and functional neuroprotection in a rodent model of stroke. Stroke 35:2206–2210
Wise AK, Fallon JB, Neil AJ, Pettingill LN, Geaney MS et al (2011) Combining cell-based therapies and neural prostheses to promote neural survival. Neurotherapeutics 8:774–787
Bolos M, Spuch C, Ordonez-Gutierrez L, Wandosell F, Ferrer I et al (2013) Neurogenic effects of beta-amyloid in the choroid plexus epithelial cells in Alzheimer’s disease. Cell Mol Life Sci 70:10
Carro E, Trejo JL, Gomez-Isla T, LeRoith D, Torres-Aleman I (2002) Serum insulin-like growth factor I regulates brain amyloid-beta levels. Nat Med 8:1390–1397
Bartek J, Bartkova J, Kyprianou N, Lalani EN, Staskova Z et al (1991) Efficient immortalization of luminal epithelial cells from human mammary gland by introduction of simian virus 40 large tumor antigen with a recombinant retrovirus. Proc Natl Acad Sci USA 88:3520–3524
Alvira-Botero X, Perez-Gonzalez R, Spuch C, Vargas T, Antequera D et al (2010) Megalin interacts with APP and the intracellular adapter protein FE65 in neurons. Mol Cell Neurosci 45:306–315
Trinchese F, Liu S, Battaglia F, Walter S, Mathews PM et al (2004) Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice. Ann Neurol 55:801–814
Antequera D, Vargas T, Ugalde C, Spuch C, Molina JA et al (2009) Cytoplasmic gelsolin increases mitochondrial activity and reduces Abeta burden in a mouse model of Alzheimer’s disease. Neurobiol Dis 36:42–50
Emerich DF, Schneider P, Bintz B, Hudak J, Thanos CG (2007) Aging reduces the neuroprotective capacity, VEGF secretion, and metabolic activity of rat choroid plexus epithelial cells. Cell Transplant 16:697–705
Vargas T, Ugalde C, Spuch C, Antequera D, Moran MJ et al (2010) Abeta accumulation in choroid plexus is associated with mitochondrial-induced apoptosis. Neurobiol Aging 31:1569–1581
Ghersi-Egea JF, Strazielle N (2002) Choroid plexus transporters for drugs and other xenobiotics. J Drug Target 10:353–357
de Lange EC (2004) Potential role of ABC transporters as a detoxification system at the blood-CSF barrier. Adv Drug Deliv Rev 56:1793–1809
Bhongsatiern J, Ohtsuki S, Tachikawa M, Hori S, Terasaki T (2005) Retinal-specific ATP-binding cassette transporter (ABCR/ABCA4) is expressed at the choroid plexus in rat brain. J Neurochem 92:1277–1280
Fujiyoshi M, Ohtsuki S, Hori S, Tachikawa M, Terasaki T (2007) 24S-hydroxycholesterol induces cholesterol release from choroid plexus epithelial cells in an apical- and apoE isoform-dependent manner concomitantly with the induction of ABCA1 and ABCG1 expression. J Neurochem 100:968–978
Hama E, Shirotani K, Iwata N, Saido TC (2004) Effects of neprilysin chimeric proteins targeted to subcellular compartments on amyloid beta peptide clearance in primary neurons. J Biol Chem 279:30259–30264
Wilcock DM, Gharkholonarehe N, Van Nostrand WE, Davis J, Vitek MP et al (2009) Amyloid reduction by amyloid-beta vaccination also reduces mouse tau pathology and protects from neuron loss in two mouse models of Alzheimer’s disease. J Neurosci 29:7957–7965
Huang HC, Jiang ZF (2009) Accumulated amyloid-beta peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer’s disease. J Alzheimers Dis 16:15–27
Rebeck GW, Hoe HS, Moussa CE (2010) Beta-amyloid1-42 gene transfer model exhibits intraneuronal amyloid, gliosis, tau phosphorylation, and neuronal loss. J Biol Chem 285:7440–7446
Matsuoka Y, Picciano M, Malester B, LaFrancois J, Zehr C et al (2001) Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer’s disease. Am J Pathol 158:1345–1354
Rozemuller AJ, van Gool WA, Eikelenboom P (2005) The neuroinflammatory response in plaques and amyloid angiopathy in Alzheimer’s disease: therapeutic implications. Curr Drug Targets CNS Neurol Disord 4:223–233
Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H et al (1999) Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400:173–177
Gasparini L, Gouras GK, Wang R, Gross RS, Beal MF et al (2001) Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling. J Neurosci 21:2561–2570
Matsumoto N, Taguchi A, Kitayama H, Watanabe Y, Ohta M et al (2010) Transplantation of cultured choroid plexus epithelial cells via cerebrospinal fluid shows prominent neuroprotective effects against acute ischemic brain injury in the rat. Neurosci Lett 469:283–288
Chen G, Chen KS, Knox J, Inglis J, Bernard A et al (2000) A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer’s disease. Nature 408:975–979
Itokazu Y, Kitada M, Dezawa M, Mizoguchi A, Matsumoto N et al (2006) Choroid plexus ependymal cells host neural progenitor cells in the rat. Glia 53:32–42
Capsoni S, Giannotta S, Cattaneo A (2002) Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice. Proc Natl Acad Sci USA 99:12432–12437
Nagahara AH, Merrill DA, Coppola G, Tsukada S, Schroeder BE et al (2009) Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer’s disease. Nat Med 15:331–337
Acknowledgments
This work was supported by grants from Instituto de Salud Carlos III (FIS 09-01636), Fundación Investigación Médica Mutua Madrileña (2008/93; 2010/0004), Fundación Ramón Areces, Ministerio de Educación y Ciencia (SAF2010-15558), and CIBERNED (BESAD-P.2010). We thank Isabel Sastre for technical assistance, and Agnieszka Krzyzanowska, PhD, for the careful revision of this manuscript.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bolos, M., Antequera, D., Aldudo, J. et al. Choroid plexus implants rescue Alzheimer’s disease-like pathologies by modulating amyloid-β degradation. Cell. Mol. Life Sci. 71, 2947–2955 (2014). https://doi.org/10.1007/s00018-013-1529-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00018-013-1529-4